Additional information
| Active substance | Trastuzumab |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | HER2 testing (immunohistochemistry or fluorescence in situ hybridization) |
| Also known as | rhuMAb HER2 |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Can cause hypertension |
| Trade name | Herceptin |
| Storage conditions | Store refrigerated at 2-8В°C (36-46В°F) |
| Chemical name | Trastuzumab |
| Formula | C6484H9996N1720O2014S44 |
| Substance class | Monoclonal antibody |
| Main action | HER2/neu receptor antagonist |
| Half-life | Approximately 28 days |
| Dosage (medical) | Typically 4 mg/kg as a loading dose followed by 2 mg/kg weekly or 6 mg/kg every three weeks |
| Dosage (sports) | Not applicable |
| Effects | Reduction in tumor growth, improved survival in breast cancer patients |
| Side effects | Fever, nausea, vomiting, infusion reactions, cardiotoxicity |
| Use in sports | None |
| Manufacturer | Roche |
LACIPIL 4 mg Glaxosmithkline
Clen 40 SINGANI PHARMA
Norvacs 5 mg Pfizer
Balkan Pharma Danabol 50 mg 60 Tabletten
Thyromazol 5 mg Abdi Ibragim
Bvs Labs Dianabol 10mg 100 Tabletten
Spiriva HandiHaler 18mg Boehringer Ingelheim
Prograf 5mg Astellas Pharma
Seretide Disckus (Advair) 250 mcg Glaxosmithkline
Champix Starter Pack Pfizer
Rovamycine 3.000.000 iu Eczacibasi
Prograf 1mg Astellas Pharma
AVELOX 400 Bayer
Clenbuterol 40 Maha Pharma
Muscoflex 8 mg Bilim
FACTIVE 320 mg Abdi Ibragim
Sp Labs Lipo-Feuer 10ml
Tavanic 500 mg Sanofi
Januvia 100mg Merckgroup
Zyban Glaxosmithkline 

Reviews
There are no reviews yet.